Optimal dose selection accounting for patient subpopulations in a randomized Phase II trial to maximize the success probability of a subsequent Phase III trial

Fumihiro Takahashi, Satoshi Morita
  • Journal of Biopharmaceutical Statistics, February 2018, Taylor & Francis
  • DOI: 10.1080/10543406.2018.1428614

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/10543406.2018.1428614

In partnership with: